Home

Our stories

Edwin Cuppen
Edwin Cuppen discusses tumour-agnostic drugs for cancer patients
Cancer medicine has traditionally focused on the site of a tumour, but in recent decades research has held out the promise of spotlighting its genetic background instead. The ultimate goal is to achieve more personalised treatment. Now that the first ‘tumour-agnostic drug’ has been authorised, that moment has finally arrived.
Vesnade Jong
Erica 1
Getting the patient’s voice into cancer research
Erica van Wuijtswinkel and Jacco van Rheenen on the importance of patient engagement
Marloesvan Amerom
Berns3
“We have underestimated the complexity of cancer.”
Anton Berns doesn’t sound like someone who is about to stop working. The 74 years old professor in Molecular Genetics talks with great enthusiasm about new technologies which, according to him, will drive the progress in cancer research the coming years.
Hidde Boersma
Open Science
Open Science: quicker access and more transparency
Oncode Investigator Bas van Steensel (NKI), is one of the Open Science advocates within Oncode Institute. Not a topic that is high on everyone's priority list, but that makes Bas extra passionate to explain the importance of it, and – not in the least – why researchers can benefit from it.
ElizeBrolsma
Research Groups
Why clinicians and fundamental researchers need each other
Oncode Investigator Wilbert Zwart and Medical Oncologist André Bergman are interviewed why clinicians and fundamental researchers need each other, and the value produced by such collaboration
ElizeBrolsma
Team
How to manage a top research group
Is there a secret recipe for a successful research group? How do you recruit the best scientists? And how do you ensure that people in your team can excel?
Lindavan den Berg
Research Strategy
How fundamental oncology will shape future cancer treatment
Two researchers, Jeanine Roodhart and Henk Verhuel, try to predict which fundamental research paths are most likely to improve the life of cancer patients in the future
Hidde Boersma
The Oncode Community Platform: Connecting researchers to create impact
Oncode Institute is a mission-driven research effort that goes beyond the competitive model of science. Within Oncode, researchers are strongly encouraged to work together because we need all available talent to outsmart cancer and impact patient’s lives. Oncode has co-created a digital tool with the research community that should help researchers find the expertise they need.
MariaHayat
Oncode Annual Conference
Annual Conference – young researchers are the future
On November 8th and 9th 2018, cancer researchers from all over The Netherlands gathered for the Oncode-CGC Annual Conference. A quick look at the audience showed that not only the speakers were a dynamic mix of people. It is safe to say that the cancer research community is young, diverse and very motivated to create impact.
ElizeBrolsma
Picture1
Medications specifically for Children with Cancer
Separate research is needed in the case of children with cancer. Children differ from adults in the types of cancer they develop. Researchers at the recently opened Princess Máxima Centre for Pediatric Oncology are looking for medications that work more specific than chemotherapy. NEMO Kennislink visited them.
OncodeInstitute
Foto Single Cell Discoveries
First Start-up Oncode Institute launched
Oncode Investigator, Alexander van Oudenaarden, is one of the pioneers in the field of single-cell sequencing. From his lab at the Hubrecht Institute the company Single Cell Discoveries was recently launched with the help of the valorization team of Oncode.
Hidde Boersma
Madelon Maurice
Fundamental Science: an uncertain endeavour into uncharted territory
Oncode invests in curiosity driven research. We asked Oncode Investigator Madelon Maurice and General Director Ton Rijnders to explain why.
Hidde Boersma